← Open Payments lookup

MARK INOCENCIO: Open Payments

NPI 1134568702 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 15 payments from 7 companies in 2025. Trend: 2023 $149 · 2024 $312 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
Braeburn Inc.5$179
Xeris Pharmaceuticals, Inc.4$71
Medtronic, Inc.1$49
Amgen Inc.2$37
Tandem Diabetes Care, Inc.1$23
Novo Nordisk Inc1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: BRIXADI, RECORLEV, MINIMED 780G, EVENITY, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, JARDIANCE.

Industry payments across NJ — which companies pay providers there.